TEST BANK FOR Advanced Practice Nursing
in the Care of Older Adults, 3rd Edition
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
,Answers51at51the51end51of51the51Chapter
Chapter 1: Changes with Aging
51 51 51 51
Multiple51Choice
Identify51the51choice51that51best51completes51the51statement51or51answers51the51question.
1. The51major51impact51of51the51physiological51changes51that51occur51with51aging51is:
A. Reduced51physiological51reserve
B. Reduced51homeostatic51 mechanisms
C. Impaired51immunological51response
D. All51of51the51above
2. The51strongest51evidence51regarding51normal51physiological51aging51is51available51through:
,A. Randomized51controlled51clinical51trials
B. Cross-sectional51studies
C. Longitudinal51studies
D. Case51control51studies
3. All51of51the51following51statements51are51true51about51labo
ratory51values51in51older51adultsexcept:
A. Reference51ranges51are51preferable
B. Abnormal51findings51are51often51due51to51physiological51aging
C. Normal51ranges51may51not51be51applicable51for51older51adults
D. Reference51values51are51not51necessarily51acceptable51values
4. Biochemical51individuality51is51best51described51as:
A. Each51individual’s51variation51is51often51much51greater51than51that51of51a51larger51group
B. The51unique51biochemical51profile51of51a51selected51population
C. The51truly51“normal”51individual—falling51within51average51range
D. Each51individual’s51variation51is51often51much51smaller51than51that51of51a51larger51group
5. Polypharmacy51ois51obest51odescribed51oas51otaking:
A. More51othan51onine51omedications51oper51oday
B. Moreothan51ofive51omedications51oper51oday
, C. Even51oa51osingle51omedication51oif51othere51ois51onot51oa51oclear51oindication51ofor51oits51ouse
D. When51oa51odrug51ois51ogiven51oto51otreat51othe51oside51oeffect51oof51oanother51odrug
51o51o5 1 o 6.51o51 Pharmacokinetic51ochanges51owithoaging51ois51oreflective51oof:
A. What51othe51odrug51odoes51oto51othe51obody
B. What51othe51obody51odoes51oto51othe51odrug
C. The51oeffect51oat51othe51osite51oof51oaction51oand51othe51otime51oand51ointensity51oof51othe51odrug
D. The51oside51oeffects51ocommonly51oassociated51owith51othe51odrug
51o51o5 1 o
7.5 1 o51All51othe51ofollowing51ostatements51oare51ofalse51oabout51odrug51oabsorption51oexcept
:
A. Antacids51oincrease51othe51obioavailability51oof51odigitalis
B. Gastric51oacidity51odecreases51owith51oage
C. Anticholinergics51oincrease51ocolonic51omotility
D. Underlying51ochronic51odisease51ohas51olittle51oimpact51oon51odrug51oabsorption
51o51o5 1 o
8.51o51All51oof51othe51ofollowing51ostatements51oare51otrue51oabout51odrug51odistributio
n51oin51othe51elderly51oexcept:
A. Drugs51odistributed51oin51owater51ohave51olower51oconcentration
B. Drugs51odistributed51oin51ofat51ohave51oless51ointense,51omore51oprolonged51oeffect
C. Drugs51ohighly51oprotein51obound51ohave51ogreater51opotential51oto51ocauseoan51oadverse51odrug51oreaction
in the Care of Older Adults, 3rd Edition
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
,Answers51at51the51end51of51the51Chapter
Chapter 1: Changes with Aging
51 51 51 51
Multiple51Choice
Identify51the51choice51that51best51completes51the51statement51or51answers51the51question.
1. The51major51impact51of51the51physiological51changes51that51occur51with51aging51is:
A. Reduced51physiological51reserve
B. Reduced51homeostatic51 mechanisms
C. Impaired51immunological51response
D. All51of51the51above
2. The51strongest51evidence51regarding51normal51physiological51aging51is51available51through:
,A. Randomized51controlled51clinical51trials
B. Cross-sectional51studies
C. Longitudinal51studies
D. Case51control51studies
3. All51of51the51following51statements51are51true51about51labo
ratory51values51in51older51adultsexcept:
A. Reference51ranges51are51preferable
B. Abnormal51findings51are51often51due51to51physiological51aging
C. Normal51ranges51may51not51be51applicable51for51older51adults
D. Reference51values51are51not51necessarily51acceptable51values
4. Biochemical51individuality51is51best51described51as:
A. Each51individual’s51variation51is51often51much51greater51than51that51of51a51larger51group
B. The51unique51biochemical51profile51of51a51selected51population
C. The51truly51“normal”51individual—falling51within51average51range
D. Each51individual’s51variation51is51often51much51smaller51than51that51of51a51larger51group
5. Polypharmacy51ois51obest51odescribed51oas51otaking:
A. More51othan51onine51omedications51oper51oday
B. Moreothan51ofive51omedications51oper51oday
, C. Even51oa51osingle51omedication51oif51othere51ois51onot51oa51oclear51oindication51ofor51oits51ouse
D. When51oa51odrug51ois51ogiven51oto51otreat51othe51oside51oeffect51oof51oanother51odrug
51o51o5 1 o 6.51o51 Pharmacokinetic51ochanges51owithoaging51ois51oreflective51oof:
A. What51othe51odrug51odoes51oto51othe51obody
B. What51othe51obody51odoes51oto51othe51odrug
C. The51oeffect51oat51othe51osite51oof51oaction51oand51othe51otime51oand51ointensity51oof51othe51odrug
D. The51oside51oeffects51ocommonly51oassociated51owith51othe51odrug
51o51o5 1 o
7.5 1 o51All51othe51ofollowing51ostatements51oare51ofalse51oabout51odrug51oabsorption51oexcept
:
A. Antacids51oincrease51othe51obioavailability51oof51odigitalis
B. Gastric51oacidity51odecreases51owith51oage
C. Anticholinergics51oincrease51ocolonic51omotility
D. Underlying51ochronic51odisease51ohas51olittle51oimpact51oon51odrug51oabsorption
51o51o5 1 o
8.51o51All51oof51othe51ofollowing51ostatements51oare51otrue51oabout51odrug51odistributio
n51oin51othe51elderly51oexcept:
A. Drugs51odistributed51oin51owater51ohave51olower51oconcentration
B. Drugs51odistributed51oin51ofat51ohave51oless51ointense,51omore51oprolonged51oeffect
C. Drugs51ohighly51oprotein51obound51ohave51ogreater51opotential51oto51ocauseoan51oadverse51odrug51oreaction
